Sozinibercept (OPT 302, VGX-300) is a soluble form of VEGFR-3, potently inhibits the activity of VEGF-C/D, which are the proangiogenic factors, inhibiting angiogenesis and vascular leakage. Sozinibercept also inhibits diabetic retinal edema in rats[1][2][3].
Molecular Weight:
(120.85 kDa)
Purity:
98.52
CAS Number:
[2568358-31-4]
Target:
VEGFR
Application Notes:
Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
